4//SEC Filing
Giaccia Amato 4
Accession 0001437749-21-027744
CIK 0001513818other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 7:28 PM ET
Size
19.3 KB
Accession
0001437749-21-027744
Insider Transaction Report
Form 4
Aravive, Inc.ARAV
Giaccia Amato
Director10% Owner
Transactions
- Exercise/Conversion
Common Stock
2021-11-30$0.24/sh+500$120→ 993,491 total - Sale
Common Stock
2021-11-30$3.22/sh−39$126→ 990,246 total - Exercise/Conversion
Stock Option
2021-11-30−12,350→ 0 totalExercise: $0.06From: 2018-10-12Exp: 2022-11-14→ Common Stock (12,350 underlying) - Exercise/Conversion
Stock Option
2021-11-30−500→ 8,620 totalExercise: $0.24From: 2018-10-12Exp: 2024-12-31→ Common Stock (500 underlying) - Exercise/Conversion
Common Stock
2021-11-30$0.06/sh+12,350$741→ 954,230 total - Sale
Common Stock
2021-11-30$3.22/sh−252$811→ 993,239 total - Exercise/Conversion
Common Stock
2021-11-30$0.24/sh+38,761$9,303→ 992,991 total - Sale
Common Stock
2021-11-30$3.22/sh−2,954$9,512→ 990,285 total - Exercise/Conversion
Stock Option
2021-11-30−38,761→ 0 totalExercise: $0.24From: 2018-10-12Exp: 2024-09-30→ Common Stock (38,761 underlying)
Footnotes (4)
- [F1]On November 14, 2012, Reporting Person was granted an option to purchase 32,500 shares of the common stock of Aravive at an exercise price of $0.02 per share. Pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of June 3, 2018 (the "Merger Agreement"), this option was converted into an option to purchase 12,350 shares of Issuer common stock (as adjusted for the stock split) at a per share exercise price of $0.06 per share (as adjusted for the stock split). The option is fully vested with respect to all of the underlying shares and exercisable as of the effective date of the merger.
- [F2]On October 1, 2014, Reporting Person was granted an option to purchase 102,000 shares of the common stock of Aravive at an exercise price of $0.09 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 38,761 shares of Issuer common stock (as adjusted for the stock split) at a per share exercise price of $0.24 per share (as adjusted for the stock split). The option is fully vested with respect to all of the underlying shares and exercisable as of the effective date of the merger.
- [F3]On December 31, 2014, Reporting Person was granted an option to purchase 24,000 shares of the common stock of Aravive at an exercise price of $0.09 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 9,120 shares of Issuer common stock (as adjusted for the stock split) at a per share exercise price of $0.24 per share (as adjusted for the stock split). The option is fully vested with respect to all of the underlying shares and exercisable as of the effective date of the merger.
- [F4]This transaction represents the sale of stock to cover the exercise price of the options.
Documents
Issuer
Aravive, Inc.
CIK 0001513818
Entity typeother
Related Parties
1- filerCIK 0001753058
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 7:28 PM ET
- Size
- 19.3 KB